PDS: Q4 Results and Clinical Programs Update | 27-Mar-2025 | 16:46 | RNS |
PDS: VERSATILE-003 Phase 3 Clinical Trial | 07-Mar-2025 | 16:26 | RNS |
PDS: up to $22mn Registered Direct Offering | 27-Feb-2025 | 16:30 | RNS |
PDS Biotech reaffirms guidance for clinical trial | 05-Feb-2025 | 15:24 | RNS |
ProAxsis: Status Update and Proposed Fundraise | 03-Feb-2025 | 07:00 | RNS |
TR-1 | 06-Jan-2025 | 16:42 | RNS |
Grant of Share Options | 31-Dec-2024 | 07:05 | RNS |
Q-Bot Fundraising | 31-Dec-2024 | 07:00 | RNS |
TR-1 | 12-Dec-2024 | 16:49 | RNS |
Wanda Health Fundraising | 09-Dec-2024 | 07:00 | RNS |
Close of Fundraising and Result of Retail Offer | 05-Dec-2024 | 07:00 | RNS |
Result of Subscription | 03-Dec-2024 | 13:24 | RNS |
WRAP Retail Offer | 03-Dec-2024 | 07:05 | RNS |
Proposed Subscription and Retail Offer; Update | 03-Dec-2024 | 07:00 | RNS |
Replacement RNS: PDS: Update, 3rd Quarter Results | 14-Nov-2024 | 15:59 | RNS |
Currency | UK Pounds |
Share Price | 40.50p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 76.50 |
52 Week Low | 40.03 |
Volume | 9,043 |
Shares Issued | 27.77m |
Market Cap | £11.25m |
Beta | 0.00 |
Value | ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth | ![]() |
---|
No dividends found |
Time | Volume / Share Price |
09:41 | 5,000 @ 40.40p |
09:24 | 2,465 @ 40.40p |
09:17 | 648 @ 40.03p |
08:53 | 930 @ 40.08p |
You are here: research